Home » Topics » Regulatory » Patents

Patents
RSS

Japanese scientists present new humanized monoclonal antibodies

Nov. 28, 2012

Novel agents for the treatment of myocardial infarction disclosed by Grindeks

Nov. 28, 2012

Amakem patents new ROCK-II inhibitors

Nov. 28, 2012

Novel IL-4/IL-13 binding proteins patented by Janssen Biotech and Molecular Partners

Nov. 28, 2012

Immune Design divulges new vaccines for HSV-2 infection

Nov. 27, 2012

Sanofi patents novel P2Y12 receptor antagonists

Nov. 27, 2012

New therapeutic nuclease compositions prepared at University of Washington

Nov. 27, 2012

Researchers at Galapagos disclose novel tyrosine-protein kinase inhibitors

Nov. 27, 2012

Janssen presents novel salts of a PDE10 inhibitor

Nov. 27, 2012

Baylor College of Medicine presents new DNA vaccines

Nov. 27, 2012

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...